Going to the dark(er) side: Stanford Medicine study shows how cancer gene tricks immune cells

A novel Stanford School of Medicine partnership uncovers a direct link between a cancer-associated gene, Myc, and sugar patterns on cancer cell surfaces that tell immune cells to stand down.

Related Keywords

Stanford ,Leicestershire ,United Kingdom ,United States ,Canada ,Canadian ,British ,American ,Benjamin Smith ,Eli Lilly ,Intervenn Bio ,Carolyn Bertozzi ,Anja Deutzmann ,Olilux Biosciences ,Krista Conger ,Redwood Biosciences ,Emerson Collective Cancer Research Fund ,School Of Humanities ,Palleon Pharmaceuticals ,Medicine Center ,Canadian Institutes Of Health Research ,University Of Iowa ,Lymphoma Society ,Stanford School Of Medicine ,University Of British Columbia ,Translational Research ,American Cancer Society ,American Society Of Hematology ,Stanford Translational Research ,Proceedings Of The National Academies Sciences ,Lymphoma Research Foundation ,Stanford University ,Office Of Communications ,Engineering Research Council Of Canada ,National Institutes Of Health ,Howard Hughes Medical Institute ,Natural Sciences ,Stanford School ,Dean Felsher ,Nobel Prize ,Applied Medicine Center ,Baker Family Director ,National Academies ,Applied Medicine ,British Columbia ,National Institutes ,Medicine Medical Scientist Training Program ,Canadian Institutes ,Health Research ,Engineering Research Council ,American Society ,American Cancer ,Genable Biosciences ,Lycia Therapeutics ,Genetics ,Ll News Featured Item 2 ,Ront Page Featured Item 2 ,Dress ,Dancer ,News ,